Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Diabetes Care ; 33(11): 2416-23, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20699433

RESUMO

OBJECTIVE: To investigate whether insulin reduces the magnitude of oxidative, nitrosative, and inflammatory stress and tissue damage responses induced by endotoxin (lipopolysaccharide [LPS]). RESEARCH DESIGN AND METHODS: Nine normal subjects were injected intravenously with 2 ng/kg LPS prepared from Escherichia coli. Ten others were infused with insulin (2 units/h) for 6 h in addition to the LPS injection along with 100 ml/h of 5% dextrose to maintain normoglycemia. RESULTS: LPS injection induced a rapid increase in plasma concentrations of nitric oxide metabolites, nitrite and nitrate (NOM), and thiobarbituric acid-reacting substances (TBARS), an increase in reactive oxygen species (ROS) generation by polymorphonuclear leukocytes (PMNLs), and marked increases in plasma free fatty acids, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), macrophage migration inhibition factor (MIF), C-reactive protein, resistin, visfatin, lipopolysaccharide binding protein (LBP), high mobility group-B1 (HMG-B1), and myoglobin concentrations. The coinfusion of insulin led to a total elimination of the increase in NOM, free fatty acids, and TBARS and a significant reduction in ROS generation by PMNLs and plasma MIF, visfatin, and myoglobin concentrations. Insulin did not affect TNF-α, MCP-1, IL-6, LBP, resistin, and HMG-B1 increases induced by the LPS. CONCLUSIONS: Insulin reduces significantly several key mediators of oxidative, nitrosative, and inflammatory stress and tissue damage induced by LPS. These effects of insulin require further investigation for its potential use as anti-inflammatory therapy for endotoxemia.


Assuntos
Endotoxinas/toxicidade , Insulina/uso terapêutico , Espécies Reativas de Oxigênio/sangue , Proteínas de Fase Aguda , Proteína C-Reativa/metabolismo , Proteínas de Transporte/sangue , Quimiocina CCL2/sangue , Humanos , Injeções Intravenosas , Interleucina-6/sangue , Fatores Inibidores da Migração de Macrófagos/sangue , Glicoproteínas de Membrana/sangue , Mioglobina/sangue , Nicotinamida Fosforribosiltransferase/sangue , Nitratos/sangue , Ácido Nítrico/sangue , Nitritos/sangue , Estresse Oxidativo/efeitos dos fármacos , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA